BriaCell Therapeutics Corp. (BCTX) Other financing activities (2022 - 2025)

BriaCell Therapeutics (BCTX) posted Other financing activities of $527764.0 for Q1 2025, up 79.97% sequentially from $293251.0 in Q4 2024.

BriaCell Therapeutics Corp. (BCTX) Other financing activities (2022 - 2025) Analysis & Trends

BriaCell Therapeutics has reported Other financing activities for 3 years, with the latest figure at $527764.0 in Q1 2025.

Quarterly Other financing activities changed N/A year-over-year to $527764.0 in Q1 2025, while the trailing twelve-month figure through Jul 2025 was $821015.0 (changed N/A YoY) and the FY2025 annual result came in at $821015.0, changed N/A from the prior year.
Other financing activities grew to $527764.0 in Q1 2025 per BCTX's latest filing, from $293251.0 in the prior quarter.
Over five years, Other financing activities peaked at $1.4 million in Q2 2022 and troughed at $293251.0 in Q4 2024.
A 3-year average of $734375.0 and a median of $527764.0 in 2025 frame the typical range for Other financing activities.

Download Data